Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

por Spencer, Andrew, Roberts, Andrew, Kennedy, Nola, Ravera, Christina, Cremers, Serge, Bilic, Sanela, Neeman, Terry, Copeman, Michael, Schran, Horst, Lynch, Kevin
Publicado 2008

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

por Kalff, Anna, Khong, Tiffany, Ramachandran, Malarmathy, Ho, P Joy, Mollee, Peter, D’Rozario, James, Taylor, Kerry, Estell, Jane, Norton, Sam, Kemp, Roslyn, Mitchell, Andrew J., Reynolds, John, Kennedy, Nola, Quach, Hang, Spencer, Andrew
Publicado 2021